Wordt geladen...
Financial Evaluation of Kidney Transplant With Hepatitis C Viremic Donors to Uninfected Recipients
Kidney transplantation with hepatitis C viremic (dHCV+) donors appears safe for recipients without HCV when accompanied by direct acting antiviral (DAA) treatment. However, US programs have been reluctant to embrace this approach due to concern about insurance coverage. While the cost of DAA treatme...
Bewaard in:
| Gepubliceerd in: | Transplant Direct |
|---|---|
| Hoofdauteurs: | , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Lippincott Williams & Wilkins
2020
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7665247/ https://ncbi.nlm.nih.gov/pubmed/33204825 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000001056 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|